Please assess the completion status of the following clinical trial:

Trial Title: Problem Adaptation Therapy (PATH) vs. Supportive Therapy in Treating Depressed, Cognitively Impaired Older Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meets Diagnostic and Statistical Manual for Mental Disorders(DSM)IV criteria for unipolar major depression~* Severity of depression greater than or equal to 17 on MADRS~* Disability as determined by at least 1 impairment in instrumental activities of daily living~* Evidence of executive dysfunction or impairment in at least one of the following cognitive domains of Dementia Rating Scale (DRS): attention, construction, conceptualization, and memory (\[scaled score less than 7\] adjusted for age and race based on Mayo's older participants normative data)~* Family member or caregiver able and willing to participate in treatment~* Not currently taking antidepressants, cholinesterase inhibitors, or memantine or on a stable dosage for 8 weeks prior to study entry with no medical recommendation for change of these agents in the near future~Exclusion Criteria:~* High suicide risk~* Axis I psychiatric disorder or substance abuse other than unipolar major depression or nonpsychotic depression~* Axis II diagnosis of antisocial personality~* Moderate to severe dementia: DRS total score corresponding to moderate or more severe impairment (scaled score less than or equal to 5)~* Acute or severe medical illness (e.g., delirium; metastatic cancer; decompensated cardiac; liver or kidney failure; major surgery; stroke; myocardial infarction during the 3 months prior to entry)~* Currently taking drugs known to cause depression (e.g., reserpine, alpha-methyl-dopa, steroids)~* Currently receiving psychotherapy~* Aphasia~* Sensory problems~* Inability to speak English

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PATH (Type: EXPERIMENTAL): Participants will receive PATH for 12 weeks
- ST-CI (Type: ACTIVE_COMPARATOR): Participants will receive ST-CI for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).